Legal Aspects of Biotechnology Invention

Legal Aspects of Biotechnology Innovation

Legal Aspect of Biotechnology Innovation

The use of aspirin in: treating and preventing coronary artery disease; has been continually discussed as a safe way for effectively helping patients, who are suffering from the condition. Yet, the underlying amounts of dosages have been creating controversy among health care professionals, as a number of studies are confirming or denying the results of one another. In this study, researchers are seeking to determine the answer to the problem, by looking at various published and unpublished studies / clinical trials.

A Description of the Field of Invention and Background of Invention

Over the last several decades, aspirin has continued to create innovative solutions for dealing with a host of medical conditions. Where, it has been shown, as being an effective treatment against coronary artery disease. Yet, there is a lack of agreement about what is right amount of dosage that a patient needs to be taking. As the U.S. Food and Drug Administration sets the acceptable range for dosages between 50 mg / d to as high as 1,300 mg / d. (Campbell, 2007, pp. 2018 -- 2024) This is because the different studies that were conducted all provide a wide range of recommended quantities. The problem is: that with the different underlying levels of health in the individual; this guideline could prove to be in accurate. Where, it does not take into account, specific factors that could give the person to small or to large of a dosage. To rectify the situation the article Aspirin Dose for the Prevention of Cardiovascular Disease, examines these underlying effects by looking at various published and unpublished research trials. Once this is complete, it provides the greatest insights, as to how the underlying dosages should be determined.

Preparation of Claims

The different claims that are going to be examined, will determine the underlying effects of taking various dosages. Where, researchers are looking at numerous studies and information, to accurately decide the correct amount of aspirin an individual should be taking.

Types of Claims

Composition Claim

1. The composition of this claim is: to determine the various types of dosages and the effects that will occur, after it has been digested by the individual. Where, researchers would look at the prescribed amounts of aspirin that is being ingested to include: 40 mg, 100 mg, 300 mg and 500 mg. As the most effective absorption rates were between: 300 mg to 500 mg. This is significant, because it shows how the higher and lower dosages can prove to be ineffective, as the absorption rate will determine how quickly the medication can reduce platelet activity. As this is imperative, in reducing the short and medium term effects of someone, who is suffering from coronary artery disease. (Campbell, 2007, pp. 2018 -- 2024)

Formulation or an Alternative Composition Claim

1. The alternate composition claim is: the long-term effects of various dosages on an individual. Where, researchers found that someone who is consistently prescribed amounts of aspirin between: 40 mg and 100 mg were able to dramatically slow platelets production. As the consistency of an aspirin regimen, would help to improve the body's ability to adjust to changes in lifestyle and diet. (Campbell, 2007, pp. 2018 -- 2024)

Method of Treatment Claim

The method of treating the different claims will be compared with: the different short, medium and long-term effects of specific facts; that could support or refute the statements of the author. (Campbell, 2007, pp. 2018 -- 2024)

Process of Manufacturing Claim

To determine the accuracy of the different claims…